Amway's business model is based on a multi-level marketing (MLM) structure, where Independent Business Owners (IBOs) can earn commissions not only from their own product sales, but also from sales made by IBOs they recruit.
IBOs can set their own retail prices for Amway products, with the difference between the wholesale price and the retail price representing their potential profit margin.
Also worth reading: How do AI tax loss harvesting strategies work in 2026 and what are the best tools available? · What are the state EITC income limits and eligibility charts for 2026? · How is AI impacting gig economy workers in 2026 and what are the financial implications?
Amway pays monthly bonuses to IBOs based on the volume and value of products sold by their "downline" - the network of IBOs they have recruited.
According to Amway's own income disclosure statement, only 48% of IBOs who remained active for a full year earned an average annual income of $2,484.
The majority (52%) of Amway IBOs never earn any commissions, and 45% quit the business every year.
Amway has paid out over $63.8 billion to its business owners since 1959, but the financial success of most IBOs appears to be the exception rather than the norm.
Amway's high product prices, emphasis on recruitment over retail sales, and the large number of inactive IBOs have led some to criticize the company's business model as resembling a pyramid scheme.
Independent studies have suggested that Amway's business structure creates strong incentives for IBOs to focus on recruiting new members rather than actual retail sales.
Amway has faced legal challenges and regulatory scrutiny in several countries over allegations that its business model exploits participants, particularly those at the bottom of the pyramid.
The company's success is largely dependent on its ability to continuously recruit new IBOs to sustain the growth of its multi-level marketing network.
Amway's profitability relies heavily on the ongoing membership fees and product purchases made by its large network of IBOs, rather than traditional retail sales to end-consumers.
Critics argue that Amway's emphasis on recruitment and the potential for financial rewards from building a "downline" can lead to a culture of exploitation and false promises among its distributors.